MolPharm Over 1500 Individual Drug Articles!

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on March 26, 2007; DOI: 10.1124/mol.107.034512


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.034512v1
71/6/1703    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sung, B.
Right arrow Articles by Aggarwal, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sung, B.
Right arrow Articles by Aggarwal, B. B.


Received for publication January 29, 2007.
Revised March 21, 2007.
Accepted for publication March 23, 2007.

Fisetin, An Inhibitor of Cyclin-Dependent Kinase 6, Down-Regulates Nuclear Factor-{kappa}B-Regulated Cell Proliferation, Antiapoptotic and Metastatic Gene Products Through The Suppression of TAK-1 and RIP Regulated I{kappa}B{alpha} Kinase Activation

Bokyung Sung 1, Manoj K. Pandey 1, Bharat B. Aggarwal 1*

1 The University of Texas M.D. Anderson Cancer Center

* Address correspondence to: E-mail: aggarwal{at}mdanderson.org

Abstract

Fisetin (3,7,3',4'-tetrahydroxyflavone) exhibits anti-inflammatory and antiproliferative effects through a mechanism that is poorly understood. Although fisetin has been cocrystalized with cyclin-dependent kinase 6 and inhibits its activity, this inhibition is not sufficient to explain various activities assigned to this flavonol. Because of the critical role of the NF-{kappa}B pathway in regulation of inflammation and proliferation of tumor cells, we postulated that fisetin modulates this pathway. To test this hypothesis, we examined the effect of fisetin on NF-{kappa}B and NF-{kappa}B-regulated gene products in vitro. We found that among nine different flavones tested fisetin was potent in suppressing TNF-induced NF-{kappa}B activation. Fisetin also suppressed the NF-{kappa}B activation induced by various inflammatory agents and carcinogens; and blocked the phosphorylation and degradation of I{kappa}B{alpha} by inhibiting I{kappa}B{alpha} (IKK) activation, which in turn led to suppression of the phosphorylation and nuclear translocation of p65. NF-{kappa}B-dependent reporter gene expression was also suppressed by fisetin, as was NF-{kappa}B reporter activity induced by TNFR1, TRADD, TRAF2, NIK, and IKK, but not that induced by p65 transfection. Fisetin also inhibited TNF-induced TAK1 and RIP activation, events that lie upstream of IKK activation. The expression of NF-{kappa}B-regulated gene products involved in antiapoptosis (cIAP-1/2, Bcl-2, Bcl-xL, XIAP, Survivin, and TRAF1), proliferation (cyclin D1, c-Myc, COX-2), invasion (ICAM-1 and MMP-9) and angiogenesis (VEGF) were also down-regulated by fisetin. This correlated with potentiation of apoptosis induced by TNF, doxorubicin, and cisplatin. Thus overall our results indicate that fisetin mediates antitumor and anti-inflammatory effects through modulation of NF-{kappa}B pathways.


Key words: NFkappaB, Mechanisms of cell killing/apoptosis


This article has been cited by other articles:


Home page
BloodHome page
B. Sung, M. K. Pandey, K. S. Ahn, T. Yi, M. M. Chaturvedi, M. Liu, and B. B. Aggarwal
Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-{kappa}B-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-{kappa}B{alpha} kinase, leading to potentiation of apoptosis
Blood, May 15, 2008; 111(10): 4880 - 4891.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
N. Khan, F. Afaq, D. N. Syed, and H. Mukhtar
Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells
Carcinogenesis, May 1, 2008; 29(5): 1049 - 1056.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics